AI Summary & Key Takeaways
AI InsightConsequently hypotony and decrease in visual acuity re-occurred due to second application of travoprost and these findings were resolved after the therapy was stopped again
📌 3 Key Takeaways
Abstract
A 73 year-old man attended for routine follow-up. He had a history of primary open angle glaucoma in the left eye which was diagnosed 2 years ago. He had been using benzalkonium chloride - free travoprost 0.004% eye drop once a day for 2 years. His best corrected visual acuity was 20/60 and intraocular pressure 5 mmHg in the left eye. Dilated fundus examination demonstrated cystoid macular edema as confirmed by optical coherence tomography. In accordance to that the therapy was discontinued until the intraocular pressure value increased and visual acuity recovered after some time. Consequently hypotony and decrease in visual acuity re-occurred due to second application of travoprost and these findings were resolved after the therapy was stopped again
Özet
Yetmiş üç yaşında erkek hasta rutin kontrol için başvurdu. Hastaya iki yıl önce primer açık açılı glokom tanısı konulmuştu. Hasta iki yıldır günde 1 damla benzalkonyum klorid içermeyen travoprost %0.004 kullanmaktaydı. Hastanın sol gözünde düzeltilmiş görme keskinliği 20/60 düzeyindeydi ve göz içi basıncı 5 mmHg idi. Dilate fundus muayenesinde ve optik koherens tomografide kistoid maküler ödem saptandı. Bunun üzerine göz içi basıncı yükselip bir süre sonra görme keskinliği düzelinceye dek tedavi kesildi. Travoprostun ikinci kez uygulanmasıyla hipotoni ve görme keskinliğinde azalma tekrar meydana geldi ve tekrar tedavi kesilince bulgular düzeldi